Some patients who need general medical care before a dental intervention can suffer increased risk for poor outcomes if they have compromised access to care.
AMA J Ethics. 2022;24(1):E6-12. doi:
10.1001/amajethics.2022.6.
A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021;23(9):E712-720. doi:
10.1001/amajethics.2021.712.